SG Americas Securities LLC Has $647,000 Position in The Chemours Company $CC

SG Americas Securities LLC lessened its stake in The Chemours Company (NYSE:CC) by 81.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,843 shares of the specialty chemicals company’s stock after selling 178,733 shares during the period. SG Americas Securities LLC’s holdings in Chemours were worth $647,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Baird Financial Group Inc. bought a new stake in shares of Chemours during the first quarter worth $148,000. Royal Bank of Canada increased its position in Chemours by 6.8% in the first quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company’s stock worth $7,926,000 after purchasing an additional 37,382 shares during the period. AQR Capital Management LLC bought a new stake in Chemours during the 1st quarter worth about $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in Chemours by 149.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company’s stock worth $593,000 after purchasing an additional 25,899 shares during the last quarter. Finally, Empowered Funds LLC acquired a new position in Chemours during the 1st quarter valued at about $403,000. 76.26% of the stock is currently owned by institutional investors.

Chemours Price Performance

Shares of CC stock opened at $16.06 on Friday. The company has a quick ratio of 0.88, a current ratio of 1.71 and a debt-to-equity ratio of 13.66. The Chemours Company has a 12-month low of $9.13 and a 12-month high of $20.07. The firm has a fifty day moving average of $12.80 and a 200-day moving average of $13.77. The firm has a market capitalization of $2.41 billion, a price-to-earnings ratio of -7.23 and a beta of 1.61.

Chemours (NYSE:CC) last issued its quarterly earnings data on Thursday, November 6th. The specialty chemicals company reported $0.20 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.04). Chemours had a positive return on equity of 35.27% and a negative net margin of 5.70%.The business had revenue of $1.50 billion for the quarter, compared to analyst estimates of $1.50 billion. During the same period in the previous year, the business posted $0.40 EPS. The business’s quarterly revenue was down .9% compared to the same quarter last year. On average, equities research analysts forecast that The Chemours Company will post 2.03 earnings per share for the current year.

Chemours Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were given a $0.0875 dividend. The ex-dividend date was Friday, November 14th. This represents a $0.35 annualized dividend and a dividend yield of 2.2%. Chemours’s payout ratio is currently -15.77%.

Analysts Set New Price Targets

Several brokerages have recently commented on CC. BMO Capital Markets reiterated an “outperform” rating and set a $20.00 price target on shares of Chemours in a research report on Monday. JPMorgan Chase & Co. lowered their target price on shares of Chemours from $15.00 to $13.00 and set a “neutral” rating for the company in a report on Wednesday, December 3rd. Weiss Ratings reissued a “sell (d)” rating on shares of Chemours in a research note on Wednesday. Truist Financial raised their price target on Chemours from $18.00 to $21.00 and gave the stock a “buy” rating in a research report on Wednesday. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $18.00 price objective on shares of Chemours in a report on Friday, January 16th. Five analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have issued a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $16.67.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.